HuagongsheHuagongshe Chemistry Print Report · For research reference only
Citric Acid → Tofacitinib Citrate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Citric Acid | HCID 311 | — |
| Reactant | 1,8-Diazabicycloundec-7ene | HCID 129662960 | — |
| Reactant | HCID 131734729 | HCID 131734729 | — |
| Solvent | Water | HCID 962 | — |
| Product | Tofacitinib Citrate | HCID 10174505 | 89.2% |
Reaction Steps
Form APO-A tofacitinib hydrochloride (0.80 g, 2.29 mmol) was dissolved in water (0.80 mL). A solution of citric acid (0.53 g, 2.75 mmol) and 1,8-diazabicycloundec-7-ene (DBU) (0.38 g, 2.52 mmol) in water (8 mL) was charged under stirring at room temperature. Solids started to form 1-2 minutes following addition. The suspension was stirred at room temperature for 4 hours then filtered and washed with water (2×5 mL) and acetone (1×3 mL). The filtered solids were dried under vacuum (35 torr) at 40° C. for approximately 5 hours to yield 1.03 g of tofacitinib citrate (1.03 g; 89%) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09260438B2 |
| Source dataset | uspto-grants-2016_02 |
| ORD ID | ord-83f270317edd4f1d8d5f02454ce4b00d |
| Source note | uspto-grants-2016_02 |